TY - JOUR
T1 - Prostaglandin Photoaffinity Probes
T2 - Synthesis And Biological Activity of Azide-Substituted 16-Phenoxy- and 17-Phenyl-PGF2αProstaglandins
AU - Kawada, Kenji
AU - Dolence, E. Kurt
AU - Morita, Hiroyuki
AU - Gerschenson, L. E.
AU - Kometani, Tadashi
AU - Watt, David S.
AU - Orlicky, David J.
AU - Fitz, Tony A.
AU - Balapure, Anil
PY - 1989/1/1
Y1 - 1989/1/1
N2 - The development of a prostaglandin PGF2aphotoaffinity probe led to the synthesis and biological evaluation of azide-substituted 17-phenyl-18,19,20-trinorprostaglandin F2aand 16-phenoxy-17,18,19,20-tetranorprostaglandin E2aderivatives. Two approaches for the preparation of iodinated versions of these prostaglandins were evaluated: (1) iodination of a phenyl azide bearing an activating hydroxyl group and (2) iodination of an aniline precursor to the phenyl azide group and subsequent conversion of the aniline to the phenyl azide. In the first approach, 17-(4-azido-2-hydroxyphenyl)-18,19,20-trinorprostaglandin F2a, 16-(5-azido-3-hydroxyphenoxy)-17,18,19,20-tetranorprostaglandin F2a, and 16-(4-azido-2-hydroxyphenoxy)-17,18,19,20-tetranorprostaglandin F2awere prepared by using the Corey synthesis, but were biologically inactive presumably as a result of the hydrophilic phenolic hydroxyl group. In the second approach, the iodination of a 17-(4-aminophenyl)-18,19,20-trinorprostaglandin F2aderivative delivered 17-(4-azido-3-iodophenyl)-18,19,20-trinorprostaglandin F2α, which exhibited competitive binding with natural [3H]PGF2α to ovine luteal cells and to plasma membranes of bovine corpora lutea. [125I]-17-(4-Azido-3-iodophenyl)-18,19,20-trinorprostaglandin F2awas utilized in a preliminary photoaffinity cross-linking experiment.
AB - The development of a prostaglandin PGF2aphotoaffinity probe led to the synthesis and biological evaluation of azide-substituted 17-phenyl-18,19,20-trinorprostaglandin F2aand 16-phenoxy-17,18,19,20-tetranorprostaglandin E2aderivatives. Two approaches for the preparation of iodinated versions of these prostaglandins were evaluated: (1) iodination of a phenyl azide bearing an activating hydroxyl group and (2) iodination of an aniline precursor to the phenyl azide group and subsequent conversion of the aniline to the phenyl azide. In the first approach, 17-(4-azido-2-hydroxyphenyl)-18,19,20-trinorprostaglandin F2a, 16-(5-azido-3-hydroxyphenoxy)-17,18,19,20-tetranorprostaglandin F2a, and 16-(4-azido-2-hydroxyphenoxy)-17,18,19,20-tetranorprostaglandin F2awere prepared by using the Corey synthesis, but were biologically inactive presumably as a result of the hydrophilic phenolic hydroxyl group. In the second approach, the iodination of a 17-(4-aminophenyl)-18,19,20-trinorprostaglandin F2aderivative delivered 17-(4-azido-3-iodophenyl)-18,19,20-trinorprostaglandin F2α, which exhibited competitive binding with natural [3H]PGF2α to ovine luteal cells and to plasma membranes of bovine corpora lutea. [125I]-17-(4-Azido-3-iodophenyl)-18,19,20-trinorprostaglandin F2awas utilized in a preliminary photoaffinity cross-linking experiment.
UR - http://www.scopus.com/inward/record.url?scp=0024489973&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024489973&partnerID=8YFLogxK
U2 - 10.1021/jm00121a046
DO - 10.1021/jm00121a046
M3 - Article
C2 - 2909739
AN - SCOPUS:0024489973
SN - 0022-2623
VL - 32
SP - 256
EP - 264
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 1
ER -